Johnson & Johnson
- Business
Johnson & Johnson earns $457M from coronavirus vaccine sales in Q1
Company said $382M came from sales outside US Johnson & Johnson earned $457 million from coronavirus vaccine sales in the…
Read More » - Business
Johnson & Johnson to split into pharmaceutical, consumer products
Company expects separation completed in 18-24 months Johnson & Johnson announced Friday it is planning to split into two companies,…
Read More » - Turkiye
Which vaccines work against the Delta variant?
As the number of coronavirus cases attributed to the Delta variant grows, so, too, have worries about our vaccines’ effectiveness…
Read More » - Turkiye
EU delays COVID-19 vaccination plan by 3 months
Head of European Commission admits bloc was late to authorize vaccines, too optimistic on manufacturing timelines The European Union has…
Read More »